Pages that link to "Q34482476"

The following pages link to Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects (Q34482476):

Displaying 17 items.

• Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease (Q24633911) (← links)
• Advances in Alzheimer's disease drug development (Q26849352) (← links)
• Biomarkers for cognitive impairment and dementia in elderly people. (Q30370745) (← links)
• Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia (Q33936708) (← links)
• Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease (Q34283149) (← links)
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers (Q35126030) (← links)
• Caring for older adults with mild cognitive impairment: an update for nurses. (Q36653357) (← links)
• Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? (Q37118083) (← links)
• Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs (Q37256805) (← links)
• Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly (Q37524486) (← links)
• The Revitalized Tau Hypothesis on Alzheimer's Disease (Q37777458) (← links)
• Role of insulin resistance in Alzheimer's disease. (Q38268394) (← links)
• Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease (Q48409075) (← links)
• Tau, a biological marker of neurodegenerative diseases (Q49077237) (← links)
• Biomarker identification for diagnosis of Alzheimer's disease. (Q53480286) (← links)
• The Effectiveness of Vitamin E Treatment in Alzheimer's Disease (Q64256652) (← links)
• Circadian Rhythm and Alzheimer's Disease. (Q64882308) (← links)